Company Monitoring Page for MannKind

latest headlines for company on cafepharma

Think Like a Brain Surgeon: Dr. Christopher James Offers Fresh Perspectives on Six Exciting Biotechs
IT Business Net
Sat, 05/17/14 - 10:38 am
Tags:
Opexa, Biocryst, Rexahn, Corcept Therapeutics, Ligand Pharmaceuticals, MannKind
Think Like A Brain Surgeon: Dr. Christopher James Offers Fresh Perspectives On 6 Exciting Biotechs
Seeking Alpha
Fri, 05/16/14 - 08:20 am
Tags:
Amgen, Biocryst, GSK, Corcept Therapeutics, Merck KGaA, Ligand Pharmaceuticals, MannKind, Pfizer, Shire, Receptos, Opexa
What's Hurting Biotechnology Stocks?
Seeking Alpha
Tue, 05/13/14 - 11:37 am
Tags:
biotech, Gilead Sciences, InterMune, MannKind, Amgen, Celgene, Biogen Idec
MannKind: Forget Earnings, All Eyes On July
Seeking Alpha
Tue, 05/13/14 - 11:21 am
Tags:
MannKind, Afrezza, diabetes
Companies Betting on the Next 10 Blockbuster Drugs
24/7WallStreet
Wed, 04/23/14 - 11:57 am
Tags:
Juxtapid, Otezla, Aegerion, Celgene, GW Pharma, Sativex, Intercept Pharma, OCA, Ironwood Pharmaceuticals, Linzess, Lpath, iSONEP, MannKind, Afrezza, Xtandi, H.P. Acthar Gel, Questcor Pharmaceuticals, eteplirsen, Sarepta Therapeutics
Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data
Yahoo/Zacks.com
Wed, 04/16/14 - 10:22 am
Tags:
MannKind, Alkermes, Gilead Sciences, ledipasvir, AbbVie, Afrezza, aripiprazole lauroxil, Pharmacyclics, Imbruvica
This Week in Biotech: The Questcor Buyout and MannKind's Giant Leap to Nowhere
Motley Fool
Sun, 04/13/14 - 10:14 am
Tags:
Questcor, MannKind, Agios Pharmaceuticals, Mallinckrodt, Alkermes, Merck
The Stalled State Of MannKind
Seeking Alpha
Fri, 04/11/14 - 11:38 am
Tags:
MannKind, diabetes, Afrezza
Oramed Can Benefit As MannKind Opens The Diabetes Market For Novel Drugs
Seeking Alpha
Tue, 04/8/14 - 11:48 am
Tags:
Oramed, MannKind, diabetes, ORMD-0801
FDA Keeps Driving Up Future Cost of Inhalable Insulin
Yahoo/247WallStreet
Mon, 04/7/14 - 12:56 pm
Tags:
FDA, inhaled insulin, diabetes, Afrezza, MannKind
MannKind Announces FDA Extends PDUFA Date for AFREZZA By 3 Months
Yahoo/Benzinga
Mon, 04/7/14 - 08:44 am
Tags:
FDA, Afrezza, diabetes, MannKind
Will The Third Time Be A Charm For MannKind? Leading Fund Managers Definitely Think So
Seeking Alpha
Sun, 04/6/14 - 10:23 am
Tags:
MannKind, Afrezza, inhaled insulin, diabetes
How MannKind Shows Depth Of The Diabetes Market
Seeking Alpha
Thu, 04/3/14 - 08:59 am
Tags:
MannKind, diabetes, Afrezza
Can MannKind Shares Double Again on FDA Approval?
24/7 Wall St
Wed, 04/2/14 - 07:46 am
Tags:
FDA, Afrezza, diabetes, MannKind
MannKind Wins U.S. Panel Backing for Its Inhaled Insulin
Bloomberg
Tue, 04/1/14 - 10:20 pm
Tags:
MannKind, inhaled insulin, Afrezza, FDA, diabetes, advisory panels
Mannkind Afrezza FDA Panel Live Blog
TheStreet.com
Tue, 04/1/14 - 08:07 am
Tags:
FDA, Afrezza, MannKind, advisory panels, insulin
Shares of MannKind Plummet Prior to Drug Advisory Meeting
Yahoo/Benzinga
Mon, 03/31/14 - 04:23 pm
Tags:
FDA, MannKind, Afrezza
Mannkind: The Best Afrezza FDA Panel Preview Ever
TheStreet.com
Mon, 03/31/14 - 09:53 am
Tags:
FDA, Afrezza, advisory panels, diabetes, MannKind
FDA staff review raises questions about MannKind diabetes device
Yahoo/Reuters
Sat, 03/29/14 - 09:13 am
Tags:
MannKind, diabetes, type 2 diabetes
Mannkind Shares Dip After FDA Group Raises Afrezza Concerns
FOX Business
Fri, 03/28/14 - 01:00 pm
Tags:
MannKind, FDA, Afrezza, insulin, diabetes

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.